BR9914288A - Forma de sal de pantoprazol - Google Patents

Forma de sal de pantoprazol

Info

Publication number
BR9914288A
BR9914288A BR9914288-0A BR9914288A BR9914288A BR 9914288 A BR9914288 A BR 9914288A BR 9914288 A BR9914288 A BR 9914288A BR 9914288 A BR9914288 A BR 9914288A
Authority
BR
Brazil
Prior art keywords
salt form
pantoprazole salt
pantoprazole
pantoprazol
relates
Prior art date
Application number
BR9914288-0A
Other languages
English (en)
Inventor
Bernhard Kohl
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9914288(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of BR9914288A publication Critical patent/BR9914288A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Patente de Invenção: <B>"FORMA DE SAL DE PANTOPRAZOL"<D>. A invenção refere-se ao dihidrato do sal de magnésio de pantoprazol.
BR9914288-0A 1998-08-18 1999-08-12 Forma de sal de pantoprazol BR9914288A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (1)

Publication Number Publication Date
BR9914288A true BR9914288A (pt) 2001-06-19

Family

ID=7881823

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914288-0A BR9914288A (pt) 1998-08-18 1999-08-12 Forma de sal de pantoprazol

Country Status (33)

Country Link
US (2) US6410569B1 (pt)
EP (1) EP1105386B1 (pt)
JP (1) JP2002523411A (pt)
KR (1) KR100657835B1 (pt)
CN (1) CN1146558C (pt)
AT (1) ATE219074T1 (pt)
AU (1) AU761715B2 (pt)
BG (1) BG65255B1 (pt)
BR (1) BR9914288A (pt)
CA (1) CA2341031C (pt)
CZ (1) CZ293734B6 (pt)
DE (3) DE19843413C1 (pt)
DK (1) DK1105386T3 (pt)
EA (1) EA004431B1 (pt)
EE (1) EE04278B1 (pt)
ES (1) ES2178896T3 (pt)
HK (1) HK1037616A1 (pt)
HR (1) HRP20010117B1 (pt)
HU (1) HU226618B1 (pt)
IL (3) IL141157A0 (pt)
ME (1) ME00562A (pt)
MX (1) MXPA01001758A (pt)
NO (1) NO319782B1 (pt)
NZ (1) NZ509761A (pt)
PL (1) PL198801B1 (pt)
PT (1) PT1105386E (pt)
RS (1) RS50071B (pt)
SI (1) SI1105386T1 (pt)
SK (1) SK285105B6 (pt)
TR (1) TR200100287T2 (pt)
UA (1) UA58605C2 (pt)
WO (1) WO2000010995A1 (pt)
ZA (1) ZA200100934B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05011699A (es) * 2003-05-06 2006-01-23 Altana Pharma Ag Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
US20050004172A1 (en) * 2003-05-19 2005-01-06 Pliva-Istrazivacki Institut D.O.O. Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes
CA2528993A1 (en) * 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
MXPA06000652A (es) * 2003-07-23 2006-03-30 Altana Pharma Ag Sales alcalinas de inhibidores de bomba de protones.
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
WO2005074929A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005077936A1 (en) * 2004-02-11 2005-08-25 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides with high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
RS52233B (en) * 2004-05-07 2012-10-31 Nycomed Gmbh THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
EP1960388A1 (en) * 2006-11-06 2008-08-27 Teva Pharmaceutical Industries Ltd. Processes for preparing substantially pure pantoprazole magnesium
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
CZ2001621A3 (cs) 2001-08-15
US6410569B1 (en) 2002-06-25
DE122005000049I1 (de) 2006-12-28
US6686379B2 (en) 2004-02-03
US20020188008A1 (en) 2002-12-12
DE122005000049I2 (de) 2007-03-29
CN1146558C (zh) 2004-04-21
HUP0103257A2 (hu) 2002-02-28
NO319782B1 (no) 2005-09-12
ATE219074T1 (de) 2002-06-15
EP1105386A1 (en) 2001-06-13
AU761715B2 (en) 2003-06-05
DE69901840D1 (de) 2002-07-18
TR200100287T2 (tr) 2001-07-23
NO20010718L (no) 2001-02-12
NZ509761A (en) 2003-08-29
JP2002523411A (ja) 2002-07-30
KR20010072487A (ko) 2001-07-31
DK1105386T3 (da) 2002-09-30
EA200100208A1 (ru) 2001-08-27
CN1318065A (zh) 2001-10-17
ES2178896T3 (es) 2003-01-01
HU226618B1 (en) 2009-04-28
ZA200100934B (en) 2002-03-04
IL141157A (en) 2007-06-17
DE69901840T2 (de) 2003-05-22
SI1105386T1 (en) 2002-12-31
DE19843413C1 (de) 2000-03-30
HK1037616A1 (en) 2002-02-15
WO2000010995A1 (en) 2000-03-02
NO20010718D0 (no) 2001-02-12
RS50071B (sr) 2009-01-22
BG65255B1 (bg) 2007-10-31
EE200100054A (et) 2002-06-17
PL345993A1 (en) 2002-01-14
CA2341031A1 (en) 2000-03-02
HRP20010117B1 (en) 2010-07-31
HUP0103257A3 (en) 2003-01-28
HRP20010117A2 (en) 2002-02-28
IL141157A0 (en) 2002-02-10
EP1105386B1 (en) 2002-06-12
ME00562B (me) 2011-12-20
CZ293734B6 (cs) 2004-07-14
PL198801B1 (pl) 2008-07-31
PT1105386E (pt) 2002-11-29
ME00562A (en) 2011-12-20
MXPA01001758A (es) 2002-04-17
UA58605C2 (uk) 2003-08-15
KR100657835B1 (ko) 2006-12-15
AU5515699A (en) 2000-03-14
YU11301A (sh) 2003-12-31
CA2341031C (en) 2006-04-04
IL141328A0 (en) 2002-03-10
BG105173A (en) 2001-11-30
SK285105B6 (sk) 2006-06-01
SK2362001A3 (en) 2001-09-11
EA004431B1 (ru) 2004-04-29
EE04278B1 (et) 2004-04-15

Similar Documents

Publication Publication Date Title
BR9914288A (pt) Forma de sal de pantoprazol
PT1056722E (pt) Sal de bi-sulfato do inibidor de protease do hiv
FR2816908B1 (fr) Unite d&#39;embrayage
NO20024869L (no) Oksygenatomdanningsprosess
IT1307274B1 (it) Fibbia.
ATE236899T1 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
IT1307057B1 (it) Fibbia.
DE69938126D1 (de) Stranggussverfahren
DE59901322D1 (de) Spriegelausbildung
MXPA01011743A (es) Arilpirimidinas substituidas 5-.
DE60129224D1 (de) Tetrazolderivate
DE29803277U1 (de) Zungenreiniger
ITMI20000629A0 (it) Composti con attivita&#39; anti-hiv
DE29902104U1 (de) Stapelleiste
DE59911430D1 (de) Zungenverbindung
FR2812905B1 (fr) Systeme d&#39;actionnement
DE29806942U1 (de) Einlegezunge
IT1316077B1 (it) Attacco per fibbia
IT1316080B1 (it) Crogiolo.
ITPE20000004A0 (it) &#34;sommergibile&#34;
ES1047993Y (es) Respirador subacuatico.
DE29905775U1 (de) 3D-Labyrinth-Würfel
ITRC20000003U1 (it) &#34;bi ala - in&#34;
ITRC20000003A1 (it) &#34;bi ala - in&#34;
ZA200110082B (en) &#34;Snatch block&#34;.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DA ATIVIDADE INVENTIVA ( ART. 8O E ART. 13 DA LPI )

B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15W Others matters related to applications: legal action concerning application

Free format text: INPI-52400.047730/12 ORIGEM: JUIZO DA 025A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0029504-62.2012.4.02.5101 ACAO ORDINARIA DE NULIDADE DA DECISAO ADMINISTRATIVA DE INDEFERIMENTO DO PEDIDO AUTOR: NYCOMED GMBH REU: AGENCIA NACIONAL DE VIGILANCIA SANITARIA - ANVISA E INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI.

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)